This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Larimar Therapeutics, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Erik Johan Wagner: Innovator in Frataxin Research
Introduction
Erik Johan Wagner is a notable inventor based in Sterling, VA (US). He has made significant contributions to the field of biochemistry, particularly in the study of frataxin and its fusion proteins. His work has implications for understanding various health conditions.
Latest Patents
Wagner holds a patent titled "Methods of Quantifying Frataxin and Frataxin Fusion Proteins." This patent represents his innovative approach to measuring these important proteins, which are crucial for cellular function and energy metabolism. He has 1 patent to his name.
Career Highlights
Throughout his career, Erik Johan Wagner has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and Larimar Therapeutics, Inc. His experience in these institutions has allowed him to contribute to significant advancements in medical research.
Collaborations
Wagner has collaborated with esteemed colleagues such as Jean-Nicholas Mess and Joan David Bettoun. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Erik Johan Wagner is a dedicated inventor whose work in frataxin research has the potential to influence future medical therapies. His contributions to the field are noteworthy and reflect his commitment to advancing scientific knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile